rs121918317
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000373299.5(STXBP1):c.1631G>A(p.Gly544Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G544C) has been classified as Pathogenic.
Frequency
Consequence
ENST00000373299.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STXBP1 | NM_003165.6 | c.1631G>A | p.Gly544Asp | missense_variant | 18/20 | ENST00000373302.8 | NP_003156.1 | |
STXBP1 | NM_001032221.6 | c.1631G>A | p.Gly544Asp | missense_variant | 18/19 | ENST00000373299.5 | NP_001027392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.1631G>A | p.Gly544Asp | missense_variant | 18/20 | 1 | NM_003165.6 | ENSP00000362399 | P3 | |
STXBP1 | ENST00000373299.5 | c.1631G>A | p.Gly544Asp | missense_variant | 18/19 | 1 | NM_001032221.6 | ENSP00000362396 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 4 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2008 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 26, 2023 | Variant summary: STXBP1 c.1631G>A (p.Gly544Asp) results in a non-conservative amino acid change in the encoded protein sequence, altering a highly conserved residue (HGMD) predicted to be important for protein conformation (Saitsu_2008). Three other missense variants affecting this amino acid have been classified as pathogenic/likely pathogenic in ClinVar (p.G544R, p.G544C, p.G544V), suggesting this is a functionally important residue. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251440 control chromosomes. c.1631G>A has been reported in the literature in individuals affected with Developmental And Epileptic Encephalopathy (Saitsu_2008, Epi4K_2013, Geisheker_2017, Yuskaitis_2018), including de novo occurrences. These data indicate that the variant is likely to be associated with disease. One publication reported expression analysis of recombinant EGFP-STXBP1 proteins in N2A cells, finding clusters of protein aggregation in a subset of cells with the variant, suggesting possible protein instability (Saitsu_2008). No submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 20, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly544 amino acid residue in STXBP1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23409955, 26514728). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects STXBP1 function (PMID: 18469812, 29538625). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt STXBP1 protein function. ClinVar contains an entry for this variant (Variation ID: 6726). This missense change has been observed in individual(s) with clinical features of early infantile epileptic encephalopathies (PMID: 18469812, 30174244). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 544 of the STXBP1 protein (p.Gly544Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at